Clinical Trial Supply USA: Investment & Opportunity
Add bookmarkClinical development continues to be the most expensive, time consuming aspect of getting a drug to market and ensuring the safe, accurate supply of clinical trial products to project sites provides yet more challenges to overcome in the process.
This infographic from our sister site Pharma IQ reveals the latest thinking on clinical trial supply and where it is going. Nearly a third of all respondents stated that CROs would be an area of active investment in the next 6 months. 50% of respondents will be running 6 or more clinical trials in the BRIC region. Find out more today!
[inlinead]
